Gerresheimer’s Activist Insider Goes All In While Analysts Stay on the Sidelines

Activist fund AOC raises stake to 16.85% with €10M+ purchases, betting against analyst pessimism as Gerresheimer faces delayed audit and postponed shareholder meeting.

The activist fund AOC has sent a powerful signal of confidence in Gerresheimer, pouring more than €10 million into the stock over recent days and raising its voting stake to 16.85%. The buying spree, which included a €2.5 million purchase by a fund linked to board member Klaus Röhrig at an average price of €25.25 per share, comes at a time when the company is wrestling with a delayed audit and a postponed shareholder meeting.

That aggressive accumulation stands in sharp contrast to the views of mainstream analysts. Barclays set a price target of just €19, while UBS went even lower, arguing the shares are worth only €12.90 and recommending clients sell. The consensus average of €24.70 is below the levels at which AOC acquired its latest block. The activist is therefore betting the market has undervalued the stock, despite widespread institutional caution.

The shares themselves have delivered mixed signals. After touching a six-month high on Wednesday, profit-taking pushed the stock back to €24.84 on Friday, down 1.43% from the previous close. Over the past month the rally has been striking — a gain of 40.66% — but the longer-term picture remains dire. The stock has lost 60.10% over the past 12 months, and the year-to-date decline stands at about 10%. The weekly performance to Friday showed a drop of around 8%.

Technically, the recovery is fragile. The 200-day moving average sits at €27.37, well above the current price, and the 50-day average is now 18.10% below the stock. The relative strength index of 28 points to an oversold condition, but also to persistent selling pressure. Any failure to hold the current level could trigger further liquidation from momentum-driven funds.

Beyond the chart, the fundamental uncertainty is the real drag. Gerresheimer postponed its ordinary annual general meeting, originally scheduled for early June, indefinitely while auditors complete their work on the 2025 financial statements and a special investigation by an external firm proceeds. Interim chief executive Uwe Röhrhoff has been working to reassure lenders, who have reportedly signaled continued support. But until the audited accounts are released — and the full impact of the Bormioli acquisition is quantified — the market lacks a clear picture of the company’s financial health.

Adding to the cautious mood, Goldman Sachs trimmed its position. The bank reported a reduction in its voting rights from 20.13% to 19.80% on May 7. While the move is modest, it amplifies the sensitivity around large shareholders’ patience in this delicate period.

For now, Gerresheimer is a study in contradictions. An activist insider is buying heavily, the stock has bounced sharply from its lows, yet the credibility of the underlying business remains unproven. The next catalyst is clear: audited numbers and clarity on credit lines. Until those arrive, the rally will struggle to convince anyone but its most committed backers.